Non-Invasive Electrocardiographic Imaging for Personalized Arrhythmia Care in Congenital Heart Disease
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT07425132, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fundacion para la Innovacion en Biomedicina (FIBMED)
- Trial code
- NCT07425132
- Record updated
- 20 February 2026
- Original description
To assess the accuracy and clinical utility of a novel non-invasive ECGI mapping system in identifying arrhythmogenic regions of interest in patients with congenital heart disease.Read full original descriptionShow less
To assess the accuracy and clinical utility of a novel non-invasive ECGI mapping system in identifying arrhythmogenic regions of interest in patients with congenital heart disease.
Inclusion: Patients with congenital pathologies and a clinical indication for an invasive electroanatomical study and/or implantation of intracavitary stimulation devices; Written informed consent form signed to participate in the study; Ability to stand upright to allow for the 3D torso reconstruction required by the ECGI system.
Exclusion: Patients under 18 years of age; Inability to undergo endocardial catheterization (e.g., pregnant or breastfeeding women); Physical or mental incapacity to understand and accept the informed consent.